[Immune modulating effect of intravenous gamma globulin in a patient with overlapping syndrome]

Rev Med Chil. 1998 Sep;126(9):1108-11.
[Article in Spanish]

Abstract

We report a 46 years old woman with a diagnosis of systemic lupus erythematosus and scleroderma overlapping syndrome. During treatment with steroids and azathioprine, the appearance of paresthesias and a progressive invalidating proximal weakness was interpreted as a steroidal myopathy. Steroidal treatment was progressively discontinued, but lupic activity and esophageal involvement exacerbated. Therefore, the use of immune modulating doses of intravenous gamma globulin (2 g/kg/total dose) was decided. The patient received this dose in two consecutive days and, 48 hours later, a notable improvement in esophageal function and general condition was verified. After six months of follow up, the disease remains inactive.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Female
  • Humans
  • Injections, Intravenous
  • Lupus Erythematosus, Systemic / drug therapy*
  • Middle Aged
  • Scleroderma, Systemic / drug therapy*
  • Syndrome
  • gamma-Globulins / therapeutic use*

Substances

  • Adjuvants, Immunologic
  • gamma-Globulins